Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Visiopharm Earns Acclaim from Frost & Sullivan for Transforming Anatomic Pathology with its Cross-platform Software Solutions
2019-03-21 20:00
Adlai Nortye Receives NMPA Approval for Pelareorep (AN1004) in China to Initiate Phase III Clinical Trials
2019-03-21 18:21
Fueling the Pharmaceutical Industry by Cutting-edge Design, InnoPack China to be Grandly Held in June
2019-03-21 15:00
Samsung BioLogics Wins 2019 CMO Leadership Awards in All Six Core Categories Three Years in a Row
2019-03-21 13:42
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody
2019-03-21 07:21
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody
2019-03-21 07:20
Beckman Coulter's New Procalcitonin Assay Helps Physicians Accurately Identify Patients at Risk for Progression to Septic Shock
2019-03-21 07:00
3SBio Unveils 2018 Annual Results: Revenue Soars by 22.7%, Normalized Net Profit Soars by 29.0%, R&D Expenses Jumps Over 40%
2019-03-21 00:14
Merck and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer
2019-03-20 18:27
Merck Opens First M Lab™ Collaboration Center in Europe
2019-03-20 17:30
Pharmaceutical Collaborations and Rare Diseases Drive the Drugs to Watch as New Blockbusters Are Forecast to Hit the Market in 2019
2019-03-20 16:00
P-MEC China to Arrive in June as Shanghai Gathers International Advanced Pharmaceutical Equipment
2019-03-20 15:00
WuXi Biologics Receives EMA GMP Certificates
2019-03-20 08:07
UK Schools Rank Last in Providing Oral Health Education, FDI Survey of 13 Countries Says
2019-03-20 08:00
I-Mab Biopharma and MorphoSys Announce Initiation of Pivotal Phase 2 Study of TJ202/MOR202 for Multiple Myeloma
2019-03-20 05:05
ACell Enters Exclusive South Korean Distribution Agreement for Wound Management Product Line
2019-03-19 18:55
Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China
2019-03-19 18:30
I-Mab Biopharma Announces Dosing of First Subject in Phase 1 Clinical Trial of Anti-GM-CSF Monoclonal Antibody TJM2 in the United States
2019-03-19 18:00
Concord Medical Announces New Appointments to Management Team
2019-03-19 17:40
Nyxoah Receives European CE Mark Approval for the Genio® System, a Disruptive Neurostimulation Solution for Obstructive Sleep Apnea Therapy
2019-03-19 16:00
1
655
656
657
658
659
963